FACTORS ASSOCIATED WITH SECUKINUMAB (SEC) RETENTION IN AXIAL SPONDYLOARTHRITIS (AXSPA): RESULTS OF THE FRENCH RETROSPECTIVE STUDY FORSYA

被引：0
|
作者：
Dougados, M. [1 ]
Lucas, J. [2 ]
Desfleurs, E. [3 ]
Claudepierre, P. [4 ]
Goupille, P. [5 ]
Ruyssen-Witrand, A. [6 ]
Saraux, A. [7 ]
Tournadre, A. [8 ]
Wendling, D. [9 ]
Lukas, C. [10 ]
机构：
[1] Hop Cochin, Dept Rheumatol, Assistance Publ Hop Paris, Paris, France
[2] RcTS Clin Res Org, Biostat, Lyon, France
[3] Novartis Pharma SAS, Med Affairs, Rueil Malmaison, France
[4] Hop Henri Mondor, Dept Rheumatol, Assistance Publ Hop Paris, Creteil, France
[5] Univ Hosp Tours, Dept Rheumatol, Tours, France
[6] Univ Hosp Toulouse, Rheumatol Ctr, Toulouse, France
[7] CHU Brest, Dept Rheumatol, Brest, France
[8] CHU Clermont Ferrand, Dept Rheumatol, Clermont Ferrand, France
[9] CHRU Besancon, Dept Rheumatol, Besancon, France
[10] Univ Hopsital Montpellier, Dept Rheumatol, Montpellier, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.1933
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
POS0300
引用
收藏
页码：398 / 398
页数：1
相关论文
共 50 条
  • [1] IMPACT OF BASELINE CRP LEVEL ON SECUKINUMAB (SEC) RETENTION IN AXIAL SPONDYLOARTHRITIS (AXSPA): RESULTS OF THE FRENCH RETROSPECTIVE STUDY FORSYA
    Goupille, P.
    Dougados, M.
    Lardy-Cleaud, A.
    Desfleurs, E.
    Claudepierre, P.
    Ruyssen-Witrand, A.
    Saraux, A.
    Tournadre, A.
    Lukas, C.
    Wendling, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 886 - 887
  • [2] Factors associated with the retention of secukinumab in patients with axial spondyloarthritis in real-world practice: results from a retrospective study (FORSYA)
    Dougados, Maxime
    Lucas, Julien
    Desfleurs, Emilie
    Claudepierre, Pascal
    Goupille, Philippe
    Ruyssen-Witrand, Adeline
    Saraux, Alain
    Tournadre, Anne
    Wendling, Daniel
    Lukas, Cedric
    RMD OPEN, 2023, 9 (01):
  • [3] Impact of the time of initiation and line of biologic therapy on the retention rate of secukinumab in axial spondyloarthritis (axSpA): data from the French multicentre retrospective FORSYA study
    Dougados, Maxime
    Lardy-Cleaud, Audrey
    Desfleurs, Emilie
    Claudepierre, Pascal
    Goupille, Philippe
    Ryussen-Witrand, Adeline
    Saraux, Alain
    Tournadre, Anne
    Wendling, Daniel
    Lukas, Cedric
    RMD OPEN, 2024, 10 (01):
  • [4] IMPACT OF THE TIME OF INITIATION AND LINE OF BIOLOGIC THERAPY ON THE RETENTION RATE OF SECUKINUMAB (SECU) IN AXIAL SPONDYLOARTHRITIS (AXSPA). DATA FROM THE FRENCH MULTICENTER RETROSPECTIVE FORSYA STUDY
    Dougados, M.
    Lardy-Cleaud, A.
    Desfleurs, E.
    Claudepierre, P.
    Goupille, P.
    Ruyssen-Witrand, A.
    Saraux, A.
    Tournadre, A.
    Wendling, D.
    Lukas, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 888 - 889
  • [5] FACTORS ASSOCIATED WITH THE RETENTION OF SECUKINUMAB (SEC) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA) IN REAL WORLD PRACTICE: RESULTS FROM THE RETROSPECTIVE FORSYA STUDY
    Ruyssen-Witrand, A.
    Lucas, J.
    Desfleurs, E.
    Claudepierre, P.
    Dougados, M.
    Goupille, P.
    Lukas, C.
    Saraux, A.
    Tournadre, A.
    Wendling, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1506 - 1506
  • [6] FACTORS ASSOCIATED WITH THE RETENTION OF SECUKINUMAB (SEC) IN PATIENTS WITH PSORIATIC ARTHRITIS (PSA) IN REAL WORLD PRACTICE: RESULTS FROM THE RETROSPECTIVE FORSYA STUDY
    Ruyssen-Witrand, A.
    Lardy-Cleaud, A.
    Desfleurs, E.
    Claudepierre, P.
    Dougados, M.
    Goupille, P.
    Lukas, C.
    Saraux, A.
    Tournadre, A.
    Wendling, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1127 - 1128
  • [7] Efficacy of Certolizumab pegol in axial Spondyloarthritis: Results of the RAPID-AxSpA-Study
    Braun, J.
    Landewe, R.
    Rudwaleit, M.
    van der Heijde, D.
    Dougados, M.
    Maksymowych, W.
    Deodhar, A.
    Stach, C.
    Hoepken, B.
    Coteur, G.
    Kielar, D.
    Fichtner, A.
    Arledge, T.
    Sieper, J.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 127 - 128
  • [8] Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis
    Armagan, Berkan
    Kilic, Levent
    Farisogullari, Bayram
    Yardimci, Gozde Kubra
    Bilgin, Emre
    Bolek, Ertugrul Cagri
    Karadag, Omer
    Bilgen, Sule Apras
    Kiraz, Sedat
    Ertenli, Ihsan
    Kalyoncu, Umut
    RHEUMATOLOGY INTERNATIONAL, 2023, 43 (01) : 147 - 156
  • [9] Drug retention rate and predictive factors of drug survival for secukinumab in radiographic axial spondyloarthritis
    Berkan Armağan
    Levent Kılıç
    Bayram Farisoğulları
    Gözde Kübra Yardımcı
    Emre Bilgin
    Ertuğrul Çağrı Bölek
    Ömer Karadağ
    Şule Apraş Bilgen
    Sedat Kiraz
    İhsan Ertenli
    Umut Kalyoncu
    Rheumatology International, 2023, 43 : 147 - 156
  • [10] TREATMENT OF AXIAL SPONDYLOARTHRITIS WITH SECUKINUMAB: A REAL-LIFE RETROSPECTIVE COHORT STUDY
    Smiljanic Tomicevic, L.
    Padjen, I.
    Martinic, M.
    Mayer, M.
    Anic, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1706 - 1706
12345